XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Dividends in excess of net income
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest
Total
Balance at Dec. 31, 2021 $ 175,000 $ 7 $ 3,395,549 $ (147,366) $ (5,503) $ 1,629 $ 3,419,316
Balance (in shares) at Dec. 31, 2021 7,000 71,285,311          
Issuance of common stock, net of issuance costs   $ 2 1,257,821       1,257,823
Issuance of common stock, net of issuance costs (in shares)   18,799,566          
Repurchase of common shares     (1,912)       (1,912)
Repurchase of common shares (in shares)   (30,366)          
Issuance of stock under the 2020 Omnibus Incentive Plan     648       648
Issuance of stock under the 2020 Omnibus Incentive Plan (in shares)   129,099          
Forfeiture of restricted stock     (61)       (61)
Forfeiture of restricted stock (in shares)   (10,186)          
Stock-based compensation     6,525       6,525
Series A preferred dividends declared for the period $ (7,437)           (7,437)
Common stock dividends and distributions declared for the period       (225,766)   (978) (226,744)
Amortization, changes in fair value, and settlement of interest rate swaps         29,054 143 29,197
Net income 7,437     145,000   598 153,035
Balance at Dec. 31, 2022 $ 175,000 $ 9 4,658,570 (228,132) 23,551 1,392 4,630,390
Balance (in shares) at Dec. 31, 2022 7,000 90,173,424          
Issuance of common stock, net of issuance costs   $ 1 689,896       689,897
Issuance of common stock, net of issuance costs (in shares)   10,267,768          
Repurchase of common shares     (2,684)       (2,684)
Repurchase of common shares (in shares)   (36,780)          
Issuance of stock under the 2020 Omnibus Incentive Plan (in shares)   129,775          
Forfeiture of restricted stock     (11)       (11)
Forfeiture of restricted stock (in shares)   (14,832)          
Stock-based compensation     8,349       8,349
Series A preferred dividends declared for the period $ (7,437)           (7,437)
Common stock dividends and distributions declared for the period       (280,863)   (1,015) (281,878)
Amortization, changes in fair value, and settlement of interest rate swaps         (6,997) (23) (7,020)
Net income 7,437     162,522   588 170,547
Balance at Dec. 31, 2023 $ 175,000 $ 10 5,354,120 (346,473) 16,554 942 5,200,153
Balance (in shares) at Dec. 31, 2023 7,000 100,519,355          
Issuance of common stock, net of issuance costs     402,938       402,938
Issuance of common stock, net of issuance costs (in shares)   6,630,112          
Repurchase of common shares     (2,281)       (2,281)
Repurchase of common shares (in shares)   (39,318)          
Issuance of stock under the 2020 Omnibus Incentive Plan (in shares)   147,656          
Forfeiture of restricted stock     (25)       (25)
Forfeiture of restricted stock (in shares)   (9,100)          
Stock-based compensation     10,830       10,830
Series A preferred dividends declared for the period $ (7,437)           (7,437)
Common stock dividends and distributions declared for the period       (305,909)   (1,042) (306,951)
Amortization, changes in fair value, and settlement of interest rate swaps         23,522 80 23,602
Net income 7,437     181,760   635 189,832
Balance at Dec. 31, 2024 $ 175,000 $ 10 $ 5,765,582 $ (470,622) $ 40,076 $ 615 $ 5,510,661
Balance (in shares) at Dec. 31, 2024 7,000 107,248,705